CH603652A5 - - Google Patents

Info

Publication number
CH603652A5
CH603652A5 CH1775172A CH1775172A CH603652A5 CH 603652 A5 CH603652 A5 CH 603652A5 CH 1775172 A CH1775172 A CH 1775172A CH 1775172 A CH1775172 A CH 1775172A CH 603652 A5 CH603652 A5 CH 603652A5
Authority
CH
Switzerland
Application number
CH1775172A
Inventor
Roland Kenith Robins
Darrell Eugene O'brien
Thomas Novinson
Robert Henry Springer
Original Assignee
Icn Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US245870A external-priority patent/US3925385A/en
Application filed by Icn Pharmaceuticals filed Critical Icn Pharmaceuticals
Publication of CH603652A5 publication Critical patent/CH603652A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH1775172A 1971-12-09 1972-12-06 CH603652A5 (enExample)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US20653871A 1971-12-09 1971-12-09
US245870A US3925385A (en) 1972-04-20 1972-04-20 6-Carbethoxy-3,7-disubstitutedpyrazolo{8 1,5a{9 pyrimidines
US27346572A 1972-07-20 1972-07-20
US29984072A 1972-10-24 1972-10-24

Publications (1)

Publication Number Publication Date
CH603652A5 true CH603652A5 (enExample) 1978-08-31

Family

ID=27498614

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1775172A CH603652A5 (enExample) 1971-12-09 1972-12-06

Country Status (15)

Country Link
JP (1) JPS4864097A (enExample)
BE (1) BE792533A (enExample)
BG (1) BG22401A3 (enExample)
CH (1) CH603652A5 (enExample)
DD (1) DD104530A5 (enExample)
DE (1) DE2257547A1 (enExample)
GB (1) GB1412017A (enExample)
HU (1) HU168530B (enExample)
IE (1) IE37189B1 (enExample)
IL (1) IL40895A (enExample)
LU (1) LU66597A1 (enExample)
NL (1) NL7216539A (enExample)
NO (1) NO137012C (enExample)
RO (1) RO62762A (enExample)
SE (1) SE398751B (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4281000A (en) * 1979-07-09 1981-07-28 American Cyanamid Company Substituted pyrazolo (1,5-a)pyrimidines and their use as anxiolytic agents
AU557300B2 (en) * 1982-03-16 1986-12-18 Farmitalia Carlo Erba S.P.A. Substituted 1h-pyrazolo(1,5-alpha)pyrimidines and processes for their preparation
ZA831407B (en) * 1982-03-25 1983-11-30 Erba Farmitalia Substituted ethenyl derivatives of 1h-pyrazolo(1,5-a)pyrimidine and process for their preparation
NZ208554A (en) * 1983-06-23 1987-06-30 American Cyanamid Co (aryl and heteroaryl)-(7-(aryl and heteroaryl)-pyrazolo (1,5-a) pyrimidin-3-yl)-methanone derivatives and pharmaceutical compositions
DE3533050A1 (de) * 1985-09-17 1987-03-26 Basf Ag 7-amino-azolo(1,5-a)pyrimidine, verfahren zu ihrer herstellung und diese enthaltende fungizide, bzw. deren verwendung als fungizide
CA1330079C (en) * 1988-10-13 1994-06-07 Michihiko Tsujitani Pyrrolo (3,2-e)pyrazolo(1,5-a)pyrimidine derivative and medicine comprising the same
ATE174917T1 (de) * 1991-04-22 1999-01-15 Otsuka Pharma Co Ltd Pyrazolo(1,5-a>pyrimidinderivate und sie enthaltende antiinflammatorische mittel
DE4333705C2 (de) * 1993-10-02 2003-10-30 Guenter Ege Arylmethylsubstituierte Pyrazolo-azine, insbesondere 3-Arylmethylpyrazolo[1,5-a]pyrimidine und Verfahren zur Herstellung von 8-Arylmethyl-pyrazolo[5,1-c][1,2,4]triazinen
DK0714898T3 (da) * 1994-06-21 2002-03-18 Otsuka Pharma Co Ltd Pyrazolo[1,5-a]primidinderivat
KR100260292B1 (ko) * 1995-09-28 2000-07-01 오쓰카 요시미쓰 진통제
FR2771631B1 (fr) * 1997-12-03 2001-02-02 Oreal Compositions de teinture des fibres keratiniques contenant des 3-amino pyrazolo-[1,5-a]-pyrimidines, procede de teinture, nouvelles 3-amino pyrazolo- [1,5-a]-pyrimidines et leur procede de preparation
US7119200B2 (en) * 2002-09-04 2006-10-10 Schering Corporation Pyrazolopyrimidines as cyclin dependent kinase inhibitors
CA2497440C (en) * 2002-09-04 2011-03-22 Schering Corporation Pyrazolopyrimidines as cyclin-dependent kinase inhibitors
US7161003B1 (en) 2002-09-04 2007-01-09 Schering Corporation Pyrazolopyrimidines as cyclin dependent kinase inhibitors
TWI252851B (en) * 2003-07-24 2006-04-11 Ferrer Int 7-substituted 3-nitro-pyrazolo[1,5-a]pyrimidines and compositions and methods related thereto
ES2222813B1 (es) * 2003-07-24 2005-12-16 Ferrer Internacional, S.A. N-(3-(3-sustituidas-pirazolo(1,5-a)pirimidin-7-il)-fenil)-sulfonamidas y composiciones y metodos relacionados.
SG11201506764WA (en) 2013-04-25 2015-09-29 Beigene Ltd Fused heterocyclic compounds as protein kinase inhibitors
EP3044234B9 (en) 2013-09-13 2020-08-26 BeiGene Switzerland GmbH Anti-pd1 antibodies and their use as therapeutics and diagnostics
TWI726608B (zh) 2014-07-03 2021-05-01 英屬開曼群島商百濟神州有限公司 抗pd-l1抗體及其作為治療及診斷之用途
JP6993056B2 (ja) 2016-07-05 2022-02-15 ベイジーン リミテッド 癌治療のためのpd-1アンタゴニスト及びraf阻害剤の組合せ
MX384627B (es) 2016-08-16 2025-03-14 Beigene Ltd Forma cristalina de (s)-7-(1-acriloilpiperidin-4-il)-2-(4-fenoxifenil)-4,5,6,7-tetra-hidropirazolo[1,5-a]pirimidin-3-carboxamida, preparacion y usos de la misma
HUE065528T2 (hu) 2016-08-19 2024-06-28 Beigene Switzerland Gmbh Zanubrutinib kombinációja anti-CD20 vagy anti-PD-1 antitesttel rák kezelésében történõ alkalmazásra
CN110461847B (zh) 2017-01-25 2022-06-07 百济神州有限公司 (S)-7-(1-(丁-2-炔酰基)哌啶-4-基)-2-(4-苯氧基苯基)-4,5,6,7-四氢吡唑并[1,5-a]嘧啶-3-甲酰胺的结晶形式、其制备及用途
KR102757960B1 (ko) 2017-06-26 2025-01-22 베이진 엘티디 간세포암(hepatocellular carcinoma: HCC)에 대한 면역 치료
CN110997677A (zh) 2017-08-12 2020-04-10 百济神州有限公司 具有改进的双重选择性的Btk抑制剂
CN111801334B (zh) 2017-11-29 2023-06-09 百济神州瑞士有限责任公司 使用包含btk抑制剂的组合治疗惰性或侵袭性b-细胞淋巴瘤
TW202446397A (zh) 2019-06-10 2024-12-01 瑞士商百濟神州瑞士有限責任公司 一種含有布魯頓氏酪胺酸激酶抑制劑的口服固體錠劑及其製備方法
US11786531B1 (en) 2022-06-08 2023-10-17 Beigene Switzerland Gmbh Methods of treating B-cell proliferative disorder

Also Published As

Publication number Publication date
IL40895A (en) 1976-12-31
NL7216539A (enExample) 1973-06-13
DD104530A5 (enExample) 1974-03-12
IE37189L (en) 1973-06-09
JPS4864097A (enExample) 1973-09-05
NO137012B (no) 1977-09-05
NO137012C (no) 1977-12-14
GB1412017A (en) 1975-10-29
LU66597A1 (enExample) 1973-03-15
BG22401A3 (bg) 1977-02-20
IE37189B1 (en) 1977-05-25
RO62762A (fr) 1978-05-15
SE398751B (sv) 1978-01-16
IL40895A0 (en) 1973-01-30
DE2257547A1 (de) 1973-06-14
BE792533A (fr) 1973-06-08
HU168530B (enExample) 1976-05-28

Similar Documents

Publication Publication Date Title
JPS4864097A (enExample)
AU2658571A (enExample)
AU2691671A (enExample)
AU2684071A (enExample)
AU2564071A (enExample)
AU2941471A (enExample)
AU2726271A (enExample)
AU2742671A (enExample)
AU2894671A (enExample)
AU2952271A (enExample)
AU2880771A (enExample)
AU2938071A (enExample)
AU2654071A (enExample)
AU2927871A (enExample)
AU2885171A (enExample)
AU2930871A (enExample)
AU2875571A (enExample)
AU2854371A (enExample)
AU2837671A (enExample)
AU2836771A (enExample)
AU2755871A (enExample)
AU2907471A (enExample)
AU2740271A (enExample)
AU2503871A (enExample)
AU2940971A (enExample)

Legal Events

Date Code Title Description
PL Patent ceased
PL Patent ceased